An efficient route to human bispecific IgG

Nature Biotechnology

Volumn 16, Issue 7, 1998, Pages 677-681

  Merchant, A Margaret ^a   Zhu, Zhenping ^a,b   Yuan, Jean Q ^a   Goddard, Audrey ^a   Adams, Camellia W ^a   Presta, Leonard G ^a   Carter, Paul ^a  

^a GENENTECH INC   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Antibody engineering; Applied immunology; Phage display

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN;

ANTIBODY SPECIFICITY; ARTICLE; BASE MISPAIRING; CHROMATOGRAPHY; DIMERIZATION; DISULFIDE BOND; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; CYTOTOXICITY, IMMUNOLOGIC; DIMERIZATION; DISULFIDES; HUMANS; IMMUNOGLOBULIN G; MODELS, MOLECULAR; MUTATION; NEOPLASM PROTEINS; PROTEIN ENGINEERING; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3; RECEPTORS, CYTOKINE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, THROMBOPOIETIN;

EID: 0031876578     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0798-677     Document Type: Article

References (41)

1. Holliger, P. and Winter, G. 1993. Engineering bispecific antibodies. Current Opin. Biotechnol. 4:446-449.
2. Carter, P., Ridgway J., and Zhu, Z. 1995. Toward the production of bispecific antibody fragments for clinical applications. J. Hematother. 4:463-470.
3. Plückthun, A. and Pack, P. 1997. New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology 3:83-105.
4. Milstein, C. and Cuello, A.C. 1983. Hybrid hybriodomas and their use in immunohistochemistry. Nature 305:537-540.
5. Suresh, M.R., Cuello, A.C., and Milstein, C. 1986. Bispecific monoclonal antibodies from hybrid hydridomas. Methods Enzymol. 121:210-228.
6. H3 domains for heavy chain heterodimerization. Protein Eng. 9:617-621.
7. Atwell, S., Ridgway, J.B.B., Wells, J.A., and Carter, P. 1997. Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J. Mol. Biol. 270:26-35.
8. Villafranca, J.E., Howell, E.E., Voet, D.H., Strobel, M.S., Ogden, R.C., Abelson, J.N., and Kraut, J. 1983. Directed mutagenesis of dihydrofolate reductase. Science 222:782-788.
9. Perry, L.J. and Wetzel, R. 1984. Disulfide bond engineered into T4 lysozyme: stabilization of the protein toward thermal inactivation. Science 276:555-557.
10. Wells, J.A. and Powers, D.P. 1986. In vivo formation and stability of engineered disulfide bonds in subtilisin. J. Biol. Chem. 261:6564-6570.
11. Nissim, A., Hoogenboom, H.R., Tomlinson, I.M., Flynn, G., Midgley, C., Lane, D., and Winter, G. 1994. Antibody fragments from a "single pot" phage display library as immunochemical reagents. EMBO J. 13:692-698.
12. Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, J.K., Pope, A.R., Earnshaw, J.C., McCafferty, J. et al. 1996. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nature Biotechnolgy 14:309-314.
13. Srinivasan, N., Sowdhamini, R., Ramakrishnan, C., and Balaram, P. 1990. Conformations of disulfide bridges in proteins. Int. J. Peptides Protein Res. 36:147-155.
14. + effectors to kill HIV-1-infected cells. J. Immunol. 153:4268-4280.
15. Plowman, G.D., Whitney, G.S., Neubauer, M.G., Green, J.M., McDonald, V.L., Todaro, G.J., and Shoyab, M. 1990. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. USA 87:4905-4909.
16. HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA 89:4285-4289.
17. HER2 monoclonal antibodies. Cancer Immunol. Immunother. 37:255-263.
18. Deisenhofer, J. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9-and 2.8 Å resolution. Biochemistry 20:2361-2370.
19. Kabat, E.A., Wu, T.T., Perry, H.M., Gottesman, K.S., and Foeller, C. (eds.). 1991. pp. 688-696 in Sequences of proteins of immunological interest, 5th ed., Vol. 1. NIH, Bethesda, MD.
20. Miller, S. 1990. Protein-protein recognition and the association of immunoglobulin constant domains. J. Mol. Biol. 216:965-973.
21. Dietsch, M.T., Smith, V.F., Cosand, W.L., Damle, N.K., Ledbetter, J.A., Linsley, P.S., and Aruffo, A. 1993. Bispecific receptor globulins, novel tools for the study of cellular interactions. Preparation and characterization of an E-selectin/P-selectin bispecific receptor globulin. J. Immunol. Methods 162:123-132.
22. Hale, G., Dyer, M.J.S., Clark, M.R., Phillips, J.M., Marcus, R., Riechmann, L. et al. 1988. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 2:1394-1399.
23. Caron, P.C., Juric, J.G., Scott, A.M., Finn, R.D., Divgi, R.D., Graham, M.C. et al. 1994. A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity. Blood 83:1760-1768.
24. Sharkey, R.M., Malik, J., Shevitz, J., Behr, T., Dunn, R., Swayne, L.C. et al. 1995. Evaluation of a complementarity-determining region-grafted (humanized) anticarcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. Cancer Res. 55:5935s-5945s.
25. HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol. 14:737-744.
26. Isaacs, J.D., Watts, R.A., Hazleman, B.L., Hale, G., Keogan, M.T., Cobbold, S.P., and Waldmann, H. 1992. Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet 340:748-752.
27. Vincenti, F., Lantz, M., Birnbaum, J., Garovoy, M., Mould, D., Hakimi, J. et al. 1997. A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation. Transplantation 63:33-38.
28. Yang, W.-P., Green, K., Pinz-Sweeney, S., Briones, A.T., Burton, D.R, and Barbas, C.F. 1995. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J. Mol. Biol. 254:392-403.
29. Schier, R., McCall, A., Adam, G.P., Marshall, K.W., Merritt, H., Yim M. et al. 1996. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J. Mol. Biol. 263:551-567.
30. Figini, M., Marks, J.D., Winter, G. and Griffiths, A.D. 1994. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation. J. Mol. Biol. 239:68-78.
31. HER2 Fv-β-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug. Cancer Res. 55:63-70.
32. Kunkel, T.A., Roberts, J.D., and Zakour, R.A. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
33. Sanger, F., Nicklen, S., and Coulson, A. R. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
34. Gorman, C.M., Gies, D.R., and McCray, G. 1990. Transient production of proteins using an adenovirus transformed cell line. DNA and Protein Engineering Techniques 2:3-10.
35. Presta, L.G., Lahr, S.J., Shields, R.L., Porter, J.P., Gorman, C.M., Fendly, B.M., and Jardieu, P. M. 1993. Humanization of an antibody directed against IgE. J. Immunol. 151:2623-2632.
36. Byrn, R.A., Mordenti, J., Lucas, C., Smith, D., Marsters, S.A., Johnson, J.S. et al. 1990. Biological properties of a CD4 immunoadhesin. Nature 344:667-670.
37. Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., Griffiths, A.D., and Winter, G. 1991. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:581-597.
38. Feng, D.F. and Doolittle, R.F. 1985. Aligning amino acid sequences: comparison of commonly used methods. J. Mol. Evol. 21:112-123.
39. Feng, D. F. and Doolittle, R. F. 1987. Progressive alignment as a prerequisite to correct phylogenetic trees. J. Mol. Evol. 25:351-360.
40. Feng, D.F. and Doolittle, R.F. 1990. Progressive alignment and phylogenetic tree construction of protein sequences. Methods Enzymol. 183:375-387.
41. Xie, M.H., Yuan, J., Adams, C., and Gurney, A. 1997. Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv. Nature Biotechnology 15:768-771.